Cite
Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition
MLA
Vadim Lesan, et al. “Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition.” HemaSphere, vol. 5, no. 1, Dec. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8471d07316acda406fae59191c1ef168&authtype=sso&custid=ns315887.
APA
Vadim Lesan, Raoul Boris Meuter, Rainer M. Bohle, Günther Schneider, Florian Rosar, Moritz Bewarder, Daniel Baumhoer, Joerg Thomas Bittenbring, Lorenz Thurner, Christian Veith, Torben Rixecker, Dieter Kohn, & Patrick Orth. (2020). Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition. HemaSphere, 5(1).
Chicago
Vadim Lesan, Raoul Boris Meuter, Rainer M. Bohle, Günther Schneider, Florian Rosar, Moritz Bewarder, Daniel Baumhoer, et al. 2020. “Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition.” HemaSphere 5 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8471d07316acda406fae59191c1ef168&authtype=sso&custid=ns315887.